Top-line data from an ongoing Phase 2 trial testing Kinevant Sciences’ experimental therapy namilumab in adults with pulmonary…
Articles by Lindsey Shapiro, PhD
The U.S. Food and Drug Administration (FDA) has greenlit a month-old request by Molecure to begin a Phase…
Molecure is seeking permission from the U.S. Food and Drug Administration (FDA) to conduct a Phase 2 clinical trial…
Only about half of sarcoidosis patients showing signs of muscle disease, or myopathy, have the small clumps of immune…
The European Commission (EC) has granted orphan drug designation to aTyr Pharma’s lead therapeutic candidate efzofitimod for treating…
Infliximab — marketed as Remicade and biosimilars — had steroid-sparing effects superior to methotrexate in the treatment of cardiac…
XTMAB-16, Xentria‘s investigational antibody-based therapy for treating sarcoidosis, was able to reduce the formation of granulomas — the…
A rare occurrence of sarcoidosis in male breast tissue was observed in an American man, according to a recent…
aTyr Pharma has received positive feedback from the U.S. Food and Drug Administration (FDA) in a meeting to discuss…
The Foundation for Sarcoidosis Research (FSR) is now accepting applications for fellowships supporting early career clinicians and…